文献速递临床试验与 GCP

MAPSS项目多模式预防中学自杀研究方案更新:一项基于区域的整群随机试验

Protocol update to a study protocol for the Multimodal Approach to Preventing Suicide in Schools (MAPSS) project: a regionally based randomised trial of an integrated response to suicide risk among secondary school students.
PubMed 文献 · Trials · 2025-09-24

本文报告MAPSS整群随机试验方案的修订内容,修订原因包括COVID-19疫情及学校场景可行性考虑,涉及知情同意数字化、延长招募与参与时间线、调整结局指标与不良事件报告流程、新增可接受性问卷,核心试验设计、纳入标准与主要结局保持不变,试验注册号为ACTRN12621000279820与ACTRN12621000770864。

要点

  • 方案更新涉及数字化知情同意、延长招募与参与时间线及加强远程参与策略。
  • 调整了结局指标与风险管理流程(含不良事件报告),核心设计、纳入标准与主要结局不变。
  • 新增自定义问卷评估研究可接受性,以提升学校场景下的可行性。

核心结论

  • 方案修订反映了全球大流行期间开展学校心理健康研究的实际挑战,调整使试验得以安全推进并优先保障参与者参与。

研究设计与样本

  • MAPSS项目为基于区域的整群随机试验,评估对中学生自杀风险的综合响应。
  • 本次为方案更新,核心试验设计、纳入标准与主要结局保持不变。
  • 试验注册于澳大利亚新西兰临床试验注册中心,ACTRN12621000279820于2021年3月12日注册,ACTRN12621000770864于2021年6月21日注册、2025年2月16日更新。

主要发现

  • 修订包括实施数字化知情同意流程、延长参与者招募与参与时间线、加强远程参与策略。
  • 调整了结局指标与风险管理方案(含不良事件报告),以兼顾参与者安全与数据连续性。
  • 新增自定义问卷以评估研究可接受性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This update outlines amendments to the MAPSS trial protocol in response to both the COVID-19 pandemic and broader feasibility considerations. While many changes were necessary to navigate pandemic-related disruptions-such as school closures and remote learning-others were made to improve feasibility in the school-based setting, independent of COVID-19. The protocol was updated to align with public health guidelines and general school practices, ensuring feasibility for continued school participation and increased support and flexibility for school communities. METHODS: Key adjustments included changes to participant-facing documentation, including implementing digital consent processes, extending timelines for participant recruitment and participation, and enhancing remote engagement strategies. Modifying outcome measures and risk management protocols, including adverse event reporting, ensured both participant safety and data continuity. Lastly, new study measures were added, such as a custom-designed questionnaire to assess study acceptability. Despite the updates, the core trial design, eligibility criteria, and primary outcomes remained unchanged. CONCLUSION: These protocol amendments reflect the pragmatic challenges of conducting school-based mental health research during a global pandemic and as part of ongoing efforts to enhance feasibility. The adjustments enabled the trial to proceed safely, prioritizing participant engagement and maintaining alignment with public health measures. TRIAL REGISTRATIONS: Australian New Zealand Clinical Trial Registry, ACTRN12621000279820, originally registered on 12 March 2021, and currently awaiting update approval. Australian New Zealand Clinical Trial Registry, ACTRN12621000770864, originally registered on 21st June 2021, and updated on 16th February 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. McKay S, Lamblin M, Bellairs-Walsh I, et al. Protocol update to a study protocol for the Multimodal Approach to Preventing Suicide in Schools (MAPSS) project: a regionally based randomised trial of an integrated response to suicide risk among secondary school students. Trials. 2025. PMID: 40993694. doi:10.1186/s13063-025-09118-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。